A vaccine for cervical cancer | Science News



Support credible science journalism.

Subscribe to Science News today.


A vaccine for cervical cancer

11:36am, November 13, 2004

From Washington, D.C., at the Interscience Conference on Antimicrobial Agents and Chemotherapy

In a preliminary study, a vaccine against a virus that can cause cancer has proved 94 percent effective in women. The success sets the stage for an enhanced version of the vaccine and the massive trial needed for government approval of the final product, which is intended to protect against the human papillomavirus (HPV).

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from Science News

From the Nature Index Paid Content